This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Arcadia Biosciences (RKDA) Q2 Earnings Miss, Increase Y/Y
by Zacks Equity Research
Arcadia Biosciences (RKDA) witnesses a solid 42% improvement in Zola sales in Q2. The company continues to invest to grow the Zola brand through mass market retailers and grocery store chains.
Arcadia Biosciences (RKDA) Q2 Earnings Miss Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -38.58% and 37.47%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Hydrofarm Holdings Group, Inc. (HYFM) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Hydrofarm (HYFM) delivered earnings and revenue surprises of -21.74% and 3.38%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Arcadia Biosciences (RKDA) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Arcadia Biosciences (RKDA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Arcadia Biosciences (RKDA) Sells GoodWheat Brand to Above Food
by Zacks Equity Research
Arcadia Biosciences (RKDA) sells its GoodWheat brand to scale up its wheat IP.
Arcadia Biosciences (RKDA) Shares Gain on Q1 Earnings Beat
by Zacks Equity Research
Arcadia Biosciences' (RKDA) Q1 results benefit from a decline in operating expenses.
Arcadia Biosciences (RKDA) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 29.37% and 4.58%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Arcadia Biosciences (RKDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
New Strong Sell Stocks for April 22nd
by Zacks Equity Research
AMN, PRG and RKDA have been added to the Zacks Rank #5 (Strong Sell) List on April 22, 2024.
Arcadia Biosciences (RKDA) Q4 Earnings Beat Mark, Sales Up Y/Y
by Zacks Equity Research
Arcadia Biosciences (RKDA) reports improved top-line results in the fourth quarter of 2023, which is aided by higher GoodWheat and GLA revenues.
Arcadia Biosciences (RKDA) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 7.46% and 35%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights like West Fraser Timber, CalMaine Foods, GrowGeneration, Hydrofarm and Arcadia Biosciences
by Zacks Equity Research
West Fraser Timber, CalMaine Foods, GrowGeneration, Hydrofarm and Arcadia Biosciences are part of the Zacks Industry Outlook article.
5 Agriculture - Products Stocks to Watch in a Challenging Industry
by Madhurima Das
The Zacks Rank for the Agriculture - Products industry paints a gloomy picture. Investors should keep an eye on these five stocks braving the industry headwinds -- West Fraser (WFG), CalMaine Foods (CALM), GrowGeneration (GRWG), Hydrofarm (HYFM) and Arcadia Biosciences (RKDA).
Zacks Industry Outlook Highlights Bunge, The Andersons and Arcadia Biosciences
by Zacks Equity Research
Bunge, The Andersons and Arcadia Biosciences have been highlighted in this Industry Outlook article.
3 Agriculture - Products Stocks to Watch in a Promising Industry
by Madhurima Das
The Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), Andersons (ANDE) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.
GrowGeneration (GRWG) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
GrowGeneration (GRWG) delivered earnings and revenue surprises of -9.09% and 1.29%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
New Strong Buy Stocks for October 25th
by Zacks Equity Research
RKDA, GHRS, GPS, RITM and EXAI have been added to the Zacks Rank #1 (Strong Buy) List on October 25, 2023.
New Strong Buy Stocks for October 17th
by Zacks Equity Research
MNTX, PGNY, GFF, RKDA and CYCC have been added to the Zacks Rank #1 (Strong Buy) List on October 17, 2023.
3 Stocks to Watch in the Thriving Agriculture - Products Industry
by Madhurima Das
The Agriculture - Products industry is set to gain from solid demand. Stocks like Bunge (BG), Andersons (ANDE) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.
Arcadia Biosciences (RKDA) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 46.34% and 2.87%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Orion (OEC) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Orion (OEC) delivered earnings and revenue surprises of -10.17% and 16.30%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
GrowGeneration (GRWG) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
GrowGeneration (GRWG) delivered earnings and revenue surprises of -28.57% and 0.15%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
5 Stocks With Rising P/E to Bet on for Solid Gains
by Sanghamitra Saha
Tap five stocks with increasing P/E ratios to try out a different approach. These stocks include Crocs (CROX), AlloVir (ALVR), Arcadia Biosciences (RKDA), The Duckhorn Portfolio (NAPA) and Genuine Parts (GPC).
Westlake Chemical (WLK) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Westlake (WLK) delivered earnings and revenue surprises of -18.37% and 5.73%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Intrepid Potash (IPI) Q2 Earnings Lag Estimates
by Zacks Equity Research
Intrepid Potash (IPI) delivered earnings and revenue surprises of -26.67% and 21.06%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?